A novel G/C single-nucleotide polymorphism in the double 28-bp repeat thymidylate synthase allele

Pharmacogenomics Journal

Volumn 6, Issue 6, 2006, Pages 421-424

  Gusella, M ^a   Bolzonella, C ^a   Crepaldi, G ^a   Ferrazzi, E ^a   Padrini, R ^b  

^a Rovigo Hospital   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT; CYTOSINE; FLUOROURACIL; FOLINIC ACID; GUANOSINE; THYMIDYLATE SYNTHASE;

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BOLUS INJECTION; BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER STAGING; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DIARRHEA; DNA EXTRACTION; ELECTROPHORESIS; FATIGUE; FEMALE; FOLLOW UP; GENE FREQUENCY; GENE SEQUENCE; GENETIC LINKAGE; GENETIC VARIABILITY; GENOME ANALYSIS; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STOMATITIS; TANDEM REPEAT; TREATMENT RESPONSE;

5' UNTRANSLATED REGIONS; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TANDEM REPEAT SEQUENCES; THYMIDYLATE SYNTHASE;

EID: 33751353924     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500401     Document Type: Article

References (10)

1. Popat S, Matakidou A, Houlston RS. Thymidylate synthase expression and prognosis in colorectal cancer: A systematic review and metaanalysis. J Clin Oncol 2004; 22: 529-536.
2. Kawakami K, Salonga D, Park JM, Danenberg KD, Uetake H, Brabender J et al. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin Cancer Res 2001; 7: 4096-4101.
3. Mandola MV, Stoehmacher J, Muller-Weeks S, Cesarone G, Yu MC, Lenz HJ et al. A novel single nucleotide polymorphism within the 5′ tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity. Cancer Res 2003; 63: 2898-2904.
4. Kawakami K, Watanabe G. Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene. Cancer Res 2003; 63: 6004-6007.
5. Graziano F, Kawakami K, Watanabe G, Ruzzo A, Humar B, Santini D et al. Association of thymidylate synthase polymorphism with gastric cancer susceptibility. Int J Cancer 2004; 112: 1010-1011.
6. Kawakami K, Graziano F, Watanabe G, Ruzzo A, Santini D, Catalano V et al. Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy. Clin Cancer Res 2005; 11: 3778-3783.
7. Marcuello E, Altes A, Del Rio E, Cesar A, Menoyo A, Baiget M. Single nucleotide polymorphism in the 5′ tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients. Int J Cancer 2004; 112: 733-737.
8. O'Connel MJ, Mailliard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 1997; 15: 246-250.
9. Miller AB, Hoogstraten B, Staquet M, Winker A. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
10. Horie N, Aiba H, Oguro K, Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene of thymidylate synthase. Cell Struct Funct 1995; 20: 191-197.